Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

NCT02940730 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT02940730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02940730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2017
Completion date
June 18, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infectious peritonitis